EdgarLookup
NT 10-Q

NT 10Q

Company
Niagen Bioscience, Inc.
Filed
May 12, 2020
Period of Report
March 31, 2020
Accession Number
0001654954-20-005192
View Document ↗ View on SEC.gov ↗